Month: December 2022
The Pharmaceutical Journal I Why mucosal vaccines could be vital to getting ahead of SARS-CoV-2

For more than 40 years, Michael Russell, a professor emeritus of microbiology and immunology at the University at Buffalo, New York, has studied the web of specialised cells and secretions that protect the body’s mucosal surfaces, including the upper respiratory tract. Yet, despite reams of evidence showing how important the mucosal immune system is, it […]

Infection Control Today I How We Can Wage a Smarter Defense Against Future Pandemics

COVID-19 is not going away, and it is the latest in the world’s pandemics. Undoubtedly, another one will come, and what can scientists and medical professionals do to prepare vaccines for the next pandemic? Seth Lederman, MD, the CEO of Tonix Pharmaceuticals, a biopharmaceutical company developing new vaccines for COVID-19, smallpox, and mpox (previously known […]

BioSpace I Athira’s Alzheimer’s Therapy Climbs Ranks in a Competitive Space

Athira Pharma’s experimental Alzheimer’s therapy, fosgonimeton, continues to show reductions in known biomarkers associated with the disease and signs of cognitive and functional improvement in patients with mild-to-moderate Alzheimer’s. On Thursday, Bothell, Wash.-based Athira presented biomarker data from the Phase II ACT-AD study showing that fosgonimeton produced reductions in biomarkers of neurodegeneration (NfL) and neuroinflammation (GFAP) compared […]